Aequus Licenses Rights to Cannabinoid Transdermal Patch to Treat Neurological Disorders
March 02, 2017 08:00 ET
|
Aequus Pharmaceuticals
VANCOUVER, BC--(Marketwired - March 02, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company") announced today that through a previously announced Research...
Aequus Provides Corporate Update on Commercial and Development Programs
August 30, 2016 08:30 ET
|
Aequus Pharmaceuticals
VANCOUVER, BC--(Marketwired - August 30, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) 2016 YTD Company Highlights: Aequus reported its first commercial revenues in Q1 of...